CT-996
CT-996-201
Phase 1 small_molecule completed
Quick answer
CT-996 for Type 2 Diabetes is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Type 2 Diabetes
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed